Inhibition of monoamine oxidase B in the brains of smokers
- 1 February 1996
- journal article
- letter
- Published by Springer Science and Business Media LLC in Nature
- Vol. 379 (6567), 733-736
- https://doi.org/10.1038/379733a0
Abstract
THE massive health problem associated with cigarette smoking is exacerbated by the addictive properties of tobacco smoke and the limited success of current approaches to cessation of smoking1. Yet little is known about the neuropharmacological actions of cigarette smoke that contribute to smoking behaviour, or why smoking is so prevalent in psychiatric disorders2 and is associated with a decreased risk of Parkinson's disease3. Here we report that brains of living smokers show a 40% decrease in the level of monoamine oxidase B (MAO B; EC 1.4.3.4) relative to non-smokers or former smokers. MAO B is involved in the breakdown of dopamine, a neurotransmitter implicated in reinforcing and motivating behaviours as well as movement. MAO B inhibition is therefore associated with enhanced activity of dopamine4, as well as with decreased production of hydrogen peroxide, a source of reactive oxygen species5. We propose that reduction of MAO B activity may synergize with nicotine to produce the diverse behavioural and epidemiological effects of smoking.This publication has 23 references indexed in Scilit:
- Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment eliminates this differenceLife Sciences, 1994
- Slow recovery of human brain MAO B after L‐Deprenyl (Selegeline) withdrawalSynapse, 1994
- Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brainLife Sciences, 1991
- The effect of long-term treatment with deprenyl on basal and L-DOPA evoked dopamine release in vitro from the corpus striatum of aged ratsJournal of Neural Transmission, 1991
- Mechanistic Positron Emission Tomography Studies: Demonstration of a Deuterium Isotope Effect in the Monoamine Oxidase‐Catalyzed Binding of [11C]l‐Deprenyl in Living Baboon BrainJournal of Neurochemistry, 1988
- BIOGENIC AMINE ADDUCTS, MONOAMINE OXIDASE INHIBITORS, AND SMOKINGThe Lancet, 1988
- Irreversible inhibition of monoamine oxidase by some components of cigarette smokeLife Sciences, 1987
- Monoamine Oxidase Activity and Monoamine Metabolism in Brains of Parkinsonian Patients Treated with l‐DeprenylJournal of Neurochemistry, 1986
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake DataJournal of Cerebral Blood Flow & Metabolism, 1983
- Low platelet monoamine oxidase activity in cigarette smokersLife Sciences, 1981